Established in 1999, Novo Holdings is the holding company of the Novo Group and manages the Foundation`s investment assets.
In addition to being the major shareholder in the Novo Group companies, Novo Holdings invests the wealth of the Foundation in two key categories: 1. Life Science Investments, which includes investing in life science
companies at all stages of development; and 2. Financial Investments, which manages a diversified portfolio of equity and fixed income securities.
Working out of Copenhagen, San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
The purpose of the investments of Novo Holdings is both to grow the assets of the Foundation and to deliver a return that the Foundation can distribute for scientific, social and humanitarian purposes to improve the health and welfare of people.